Johnson & Johnson posts mixed results, narrows full-year guidance
) reported mixed financial results for the first quarter of 2024, with adjusted earnings per share slightly surpassing analyst expectations, while revenue fell marginally short of estimates. The healthcare giant posted an adjusted EPS of $2.71, which was $0.07 higher than the consensus estimate of $2.64. However, quarterly revenue was a hair's breadth away from consensus, coming in at $21.38 billion against the expected $21.4 billion.
Joaquin Duato, Chairman and CEO, commented on the results, highlighting the company's"solid first quarter performance" and the strides made in their portfolio and pipeline. He emphasized Johnson & Johnson's unique impact across healthcare and the milestones reached during the quarter that reinforce their status as an innovation leader.
Looking ahead, Johnson & Johnson has increased the midpoint for its full-year 2024 operational sales and adjusted operational EPS guidance, signaling confidence in continued growth. The company expects sales of $88 billion to $88.4 billion, compared to the previous forecast of $87.8 billion to $88.6 billion. JNJ sees adjusted earnings of $10.57 to $10.72 per share, compared to the previous guidance of $10.55 to $10.75 per share.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Nvidia and Johnson & Johnson to develop new AI applications for surgeryJohnson & Johnson MedTech and Nvidia are developing new artificial intelligence applications for surgery.
Read more »
Nvidia and Johnson & Johnson to develop new AI applications for surgeryJohnson & Johnson MedTech and Nvidia are developing new artificial intelligence applications for surgery.
Read more »
Jim Cramer names some of the non-tech Nvidia partners to watchCNBC’s Jim Cramer said Getty, Shutterstock, Medtronic, GE Healthcare and Johnson & Johnson are potential winners.
Read more »
Jim Cramer names some of the non-tech Nvidia partners to watchCNBC's Jim Cramer said Getty, Shutterstock, Medtronic, GE Healthcare and Johnson & Johnson are potential winners.
Read more »
Jim Cramer names some non-tech Nvidia partners to watchCNBC’s Jim Cramer said Getty, Shutterstock, Medtronic, GE Healthcare and Johnson & Johnson are potential winners.
Read more »
Aaron Taylor-Johnson Reacts to Critics of Sam Taylor-Johnson MarriageAaron Taylor-Johnson candidly discussed criticism of his marriage to Sam Taylor-Johnson, who is more than 20 years his senior
Read more »